Maeda Takahiro

Affiliation and department：
Job title：教授
Homepage URL (2)： https://precision.kyushu-u.ac.jp , https://precision.kyushu-u.ac.jp/en/

Research field (1)： Hematology and oncology

Research keywords (2)： Leukemia , Hematopoiesis

Research theme for competitive and other funds (1)：

2020 - 2025 Development of novel therapeutic strategies for therapy-refractory leukemia

Papers (64)：

Tatsuya Terasaki, Semba Y, Kensuke Sasaki, Hiroshi Imanaga, Setoguchi K, Yamauchi T, Shigeki Hirabayashi, Nakao F, Akahane K, Inukai T, et al. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells. Leukemia. 2024
Ryo Yanagiya, Miyatake Y, Watanabe N, Shimizu T, Kanamori A, Masaya Ueno, Okabe S, Joaquim Carreras, Nakayama S, Hasegawa A, et al. Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia. Leukemia. 2024
Hiroshi Imanaga, Yuichiro Semba, Kensuke Sasaki, Kiyoko Setoguchi, Hillary Maniriho, Takuji Yamauchi, Tatsuya Terasaki, Shigeki Hirabayashi, Fumihiko Nakao, Jumpei Nogami, et al. Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells. Blood Neoplasia. 2024
Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, et al. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO Precision Oncology. 2024. 8
Yasunori Kogure, Handa H, Yuta Ito, Masaki Ri, Horigome Y, Iino M, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, et al. ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone. Blood. 2024

ｍore...

Education (2)：

Work history (9)：

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page